Thermal
@thermalpr.com
The visionaries driving society’s greatest scientific and medical advances choose Thermal to communicate how they Impact Human Health™
thermalpr.com
thermalpr.com
Pinned
Thermal
@thermalpr.com
· Jan 13
In 2024, Thermal continued to accelerate the understanding and adoption of the world’s most innovative biotechnologies, and achieved numerous PR industry milestones.
Reposted by Thermal
We're excited to share breakthrough preclinical data across our cardiometabolic pipeline presented at #AHA25, highlighting our comprehensive strategy to address the key drivers of #ASCVD.
Thanks to Fierce Biotech‘s Darren Incorvaia for the feature:
www.fiercebiotech.com/research/scr...
Thanks to Fierce Biotech‘s Darren Incorvaia for the feature:
www.fiercebiotech.com/research/scr...
November 17, 2025 at 6:53 PM
We're excited to share breakthrough preclinical data across our cardiometabolic pipeline presented at #AHA25, highlighting our comprehensive strategy to address the key drivers of #ASCVD.
Thanks to Fierce Biotech‘s Darren Incorvaia for the feature:
www.fiercebiotech.com/research/scr...
Thanks to Fierce Biotech‘s Darren Incorvaia for the feature:
www.fiercebiotech.com/research/scr...
Reposted by Thermal
1/2 From IGI Founder @jenniferdoudna.bsky.social: “Congratulations to my colleagues Omar Yaghi & John Clarke — the two latest UC Berkeley Nobel Laureates! Omar’s development of metal-organic frameworks changed the way we capture carbon, store energy & harvest water from desert air. shorturl.at/GpBsu
UC Berkeley’s Omar Yaghi shares 2025 Nobel Prize in Chemistry - Berkeley News
Yaghi created a field called reticular chemistry, which involves stitching together molecular building blocks to form porous structures — metal-organic frameworks (MOFs) — with myriad applications.
news.berkeley.edu
October 8, 2025 at 6:22 PM
1/2 From IGI Founder @jenniferdoudna.bsky.social: “Congratulations to my colleagues Omar Yaghi & John Clarke — the two latest UC Berkeley Nobel Laureates! Omar’s development of metal-organic frameworks changed the way we capture carbon, store energy & harvest water from desert air. shorturl.at/GpBsu
Reposted by Thermal
From IGI Founder Jennifer Doudna: "Jane Goodall showed us what a life in science could look like: rigorous discovery paired with fierce advocacy for what you study. She gave the world six decades of groundbreaking research on chimpanzees and their habitats... 1/2
October 2, 2025 at 4:51 AM
From IGI Founder Jennifer Doudna: "Jane Goodall showed us what a life in science could look like: rigorous discovery paired with fierce advocacy for what you study. She gave the world six decades of groundbreaking research on chimpanzees and their habitats... 1/2
Reposted by Thermal
Ahead of #WorldHeartDay, Taylor Swift recently raised an important reminder: heart disease is the leading cause of death, and one person dies from it every 34 seconds.
For some, including her father, a routine stress test revealed severe disease early enough to undergo surgery.
For some, including her father, a routine stress test revealed severe disease early enough to undergo surgery.
September 30, 2025 at 12:25 AM
Ahead of #WorldHeartDay, Taylor Swift recently raised an important reminder: heart disease is the leading cause of death, and one person dies from it every 34 seconds.
For some, including her father, a routine stress test revealed severe disease early enough to undergo surgery.
For some, including her father, a routine stress test revealed severe disease early enough to undergo surgery.
Reposted by Thermal
An important piece in @forbes.com by Leaps By Bayer highlighting the dangers of high cholesterol, the urgent need for solutions beyond statins, and Scribe’s advances developing #CRISPR gene editing and epigenetic silencing therapies for cardiometabolic disease.
www.forbes.com/sites/juerge...
www.forbes.com/sites/juerge...
Treating High Cholesterol Could Become A One-And-Done Treatment
Gene editing and epigenetic silencing offer two ways of changing the basic biology of cholesterol for future treatments beyond statins.
www.forbes.com
September 25, 2025 at 4:31 PM
An important piece in @forbes.com by Leaps By Bayer highlighting the dangers of high cholesterol, the urgent need for solutions beyond statins, and Scribe’s advances developing #CRISPR gene editing and epigenetic silencing therapies for cardiometabolic disease.
www.forbes.com/sites/juerge...
www.forbes.com/sites/juerge...
Check out ON CRISPR: The Story of Jennifer Doudna - a new podcast from Walter Isaacson about the story of @jenniferdoudna.bsky.social - CRISPR co-inventor, Nobel laureate, @innovativegenomics.bsky.social founder - and key updates, including the case of Baby KJ. podcasts.apple.com/us/podcast/o...
ON CRISPR Episode 1: Beginnings
Podcast Episode · ON CRISPR: The Story of Jennifer Doudna with Walter Isaacson · S3 E1 · 26m
podcasts.apple.com
September 12, 2025 at 10:28 PM
Check out ON CRISPR: The Story of Jennifer Doudna - a new podcast from Walter Isaacson about the story of @jenniferdoudna.bsky.social - CRISPR co-inventor, Nobel laureate, @innovativegenomics.bsky.social founder - and key updates, including the case of Baby KJ. podcasts.apple.com/us/podcast/o...
Reposted by Thermal
📣 Presenting new breakthrough data from two of our core platforms 📣
We're proud to showcase the success of our Lp(a)-lowering therapy STX-1200 and novel #AI platform, DeepXE, for next-generation #CRISPR-based therapeutics.
More details in our link below 👇
We're proud to showcase the success of our Lp(a)-lowering therapy STX-1200 and novel #AI platform, DeepXE, for next-generation #CRISPR-based therapeutics.
More details in our link below 👇
September 9, 2025 at 4:09 PM
📣 Presenting new breakthrough data from two of our core platforms 📣
We're proud to showcase the success of our Lp(a)-lowering therapy STX-1200 and novel #AI platform, DeepXE, for next-generation #CRISPR-based therapeutics.
More details in our link below 👇
We're proud to showcase the success of our Lp(a)-lowering therapy STX-1200 and novel #AI platform, DeepXE, for next-generation #CRISPR-based therapeutics.
More details in our link below 👇
Thanks to Amy Marcus, Alex Janin, and Shane Shifflett @wsj.com for covering the $5B longevity investment landscape, including our clients BioAge and Retro, and the ecosystem of companies working to translate aging research into therapies for longer, healthier lives.
www.wsj.com/health/welln...
www.wsj.com/health/welln...
The Billionaires Fueling the Quest for Longer Life
A network of ultrawealthy investors including Peter Thiel and Sam Altman are infusing the longevity industry with cash and making big bets on where the science is headed.
www.wsj.com
September 8, 2025 at 4:05 AM
Thanks to Amy Marcus, Alex Janin, and Shane Shifflett @wsj.com for covering the $5B longevity investment landscape, including our clients BioAge and Retro, and the ecosystem of companies working to translate aging research into therapies for longer, healthier lives.
www.wsj.com/health/welln...
www.wsj.com/health/welln...
Reposted by Thermal
This fall, we are thrilled to present our latest updates on our #CRISPR genetic and epigenetic editing therapies, new machine learning approach, and corporate strategy at several premier conferences.
If you’ll be at #ECCongress, #CGMesa25, and others, read on for more details 👇
If you’ll be at #ECCongress, #CGMesa25, and others, read on for more details 👇
August 25, 2025 at 1:07 PM
This fall, we are thrilled to present our latest updates on our #CRISPR genetic and epigenetic editing therapies, new machine learning approach, and corporate strategy at several premier conferences.
If you’ll be at #ECCongress, #CGMesa25, and others, read on for more details 👇
If you’ll be at #ECCongress, #CGMesa25, and others, read on for more details 👇
Reposted by Thermal
Exclusive: I talked with leaders of OpenAI and Retro Bio about new lab results from an AI protein model called GPT-4b micro.
While the model won't be released publicly, the research shows how LLMs could be applied to life sciences research:
endpoints.news/openai-retro...
While the model won't be released publicly, the research shows how LLMs could be applied to life sciences research:
endpoints.news/openai-retro...
Exclusive: OpenAI, Retro Bio detail lab results with AI protein model, plan use in drug program
OpenAI and Retro Biosciences report AI-made proteins showed 50x better cell reprogramming using modified Yamanaka factors, with potential therapeutic applications
endpoints.news
August 22, 2025 at 3:05 PM
Exclusive: I talked with leaders of OpenAI and Retro Bio about new lab results from an AI protein model called GPT-4b micro.
While the model won't be released publicly, the research shows how LLMs could be applied to life sciences research:
endpoints.news/openai-retro...
While the model won't be released publicly, the research shows how LLMs could be applied to life sciences research:
endpoints.news/openai-retro...
Reposted by Thermal
Exclusive: Formation Bio raised a $372M Series D last year.
Later today, the New York biopharma will announce its first licensing deal since raising that money — bringing in a CD226 antibody from the Spanish biotech IMIDomics.
My latest for @endpts.com: endpoints.news/exclusive-fo...
Later today, the New York biopharma will announce its first licensing deal since raising that money — bringing in a CD226 antibody from the Spanish biotech IMIDomics.
My latest for @endpts.com: endpoints.news/exclusive-fo...
Exclusive: Formation licenses first drug since $372M raise, eyes more deals in 2025
Formation Bio licenses first-in-class anti-CD226 antibody from IMIDomics for IBD treatment, marking first drug acquisition since $372M Series D raise in 2023.
endpoints.news
July 29, 2025 at 12:20 PM
Exclusive: Formation Bio raised a $372M Series D last year.
Later today, the New York biopharma will announce its first licensing deal since raising that money — bringing in a CD226 antibody from the Spanish biotech IMIDomics.
My latest for @endpts.com: endpoints.news/exclusive-fo...
Later today, the New York biopharma will announce its first licensing deal since raising that money — bringing in a CD226 antibody from the Spanish biotech IMIDomics.
My latest for @endpts.com: endpoints.news/exclusive-fo...
CRISPR pioneer and Nobel laureate @jenniferdoudna.bsky.social is featured in the inaugural issue of The Shift. This first issue honors Gloria Steinem's legacy and brings together 90 extraordinary women whose work is opening doors for future generations. theshiftison.com/jennifer-dou...
July 29, 2025 at 4:50 AM
CRISPR pioneer and Nobel laureate @jenniferdoudna.bsky.social is featured in the inaugural issue of The Shift. This first issue honors Gloria Steinem's legacy and brings together 90 extraordinary women whose work is opening doors for future generations. theshiftison.com/jennifer-dou...
Reposted by Thermal
We’re thrilled to announce IGI–Bakar Labs. This new building will allow the IGI to continue expanding our impact in health and agricultural applications of #CRISPR, and will be shared with the Bakar Labs incubator for growing biotech companies. Learn more: news.berkeley.edu/2025/07/17/c...
CRISPR researchers and startup entrepreneurs will share new building in UC Berkeley's Innovation Zone - Berkeley News
A planned addition to the campus's Innovation Zone will expand lab space for the Innovative Genomics Institute and build out the largest innovation hub — Bakar Labs — at any U.S. university.
news.berkeley.edu
July 17, 2025 at 9:05 PM
We’re thrilled to announce IGI–Bakar Labs. This new building will allow the IGI to continue expanding our impact in health and agricultural applications of #CRISPR, and will be shared with the Bakar Labs incubator for growing biotech companies. Learn more: news.berkeley.edu/2025/07/17/c...
Reposted by Thermal
A new Pediatric Center for CRISPR Cures builds on the recent saved life of Baby KJ, who expeditiously had bespoke in vivo base genome editing
@jenniferdoudna.bsky.social @doudna-lab.bsky.social
@innovativegenomics.bsky.social
@chanzuckerberg.bsky.social
erictopol.substack.com/p/new-center...
@jenniferdoudna.bsky.social @doudna-lab.bsky.social
@innovativegenomics.bsky.social
@chanzuckerberg.bsky.social
erictopol.substack.com/p/new-center...
July 8, 2025 at 1:33 PM
A new Pediatric Center for CRISPR Cures builds on the recent saved life of Baby KJ, who expeditiously had bespoke in vivo base genome editing
@jenniferdoudna.bsky.social @doudna-lab.bsky.social
@innovativegenomics.bsky.social
@chanzuckerberg.bsky.social
erictopol.substack.com/p/new-center...
@jenniferdoudna.bsky.social @doudna-lab.bsky.social
@innovativegenomics.bsky.social
@chanzuckerberg.bsky.social
erictopol.substack.com/p/new-center...
Reposted by Thermal
We're excited to announce that the IGI is teaming up with @chanzuckerberg.bsky.social to create a new center for pediatric #CRISPR cures @UCSF + @ucberkeleyofficial.bsky.social building on the recent success of an on-demand CRISPR therapy for Baby KJ. Read more: ow.ly/XUQH50Wmt7U
July 8, 2025 at 4:44 PM
We're excited to announce that the IGI is teaming up with @chanzuckerberg.bsky.social to create a new center for pediatric #CRISPR cures @UCSF + @ucberkeleyofficial.bsky.social building on the recent success of an on-demand CRISPR therapy for Baby KJ. Read more: ow.ly/XUQH50Wmt7U
Reposted by Thermal
On the blog, we’re diving into data from our new preprint covering Iterative Mapping of proteoforms. Today we focus on the method, its benefits, and why the analysis of tau proteoforms is a great exemplar for the power of this work:
www.nautilus.bio/blog/iterati...
#Proteomics #Proteoforms
www.nautilus.bio/blog/iterati...
#Proteomics #Proteoforms
Iterative Mapping of proteoforms may reveal novel biology and new drug targets
Learn how Iterative Mapping of proteoforms can provide novel insights into biology with tau proteoforms as exemplars.
www.nautilus.bio
July 1, 2025 at 4:30 PM
On the blog, we’re diving into data from our new preprint covering Iterative Mapping of proteoforms. Today we focus on the method, its benefits, and why the analysis of tau proteoforms is a great exemplar for the power of this work:
www.nautilus.bio/blog/iterati...
#Proteomics #Proteoforms
www.nautilus.bio/blog/iterati...
#Proteomics #Proteoforms
Agenus and Noetik announced a collaboration to develop AI-enabled predictive biomarkers for BOT/BAL using foundation models of “virtual cell” biology. www.businesswire.com/news/home/20...
Agenus and Noetik Enter Collaboration to Develop AI-Enabled Predictive Biomarkers for BOT/BAL Using Foundation Models of Virtual Cell Biology
Agenus and Noetik Enter Collaboration to Develop AI-Enabled Predictive Biomarkers for BOT/BAL Using Foundation Models of Virtual Cell Biology
www.businesswire.com
June 19, 2025 at 4:05 PM
Agenus and Noetik announced a collaboration to develop AI-enabled predictive biomarkers for BOT/BAL using foundation models of “virtual cell” biology. www.businesswire.com/news/home/20...
Joe Betts-LaCroix (CEO of Retro Bio) has bigger concerns - he wants to add another ten years to the lifespan of half the world’s population.
“I’d like to know how my body works and, if it’s going to break, I’d like to know how to prevent that.”
www.thetimes.com/world/europe...
“I’d like to know how my body works and, if it’s going to break, I’d like to know how to prevent that.”
www.thetimes.com/world/europe...
I witnessed the birth of an immortality cult — surely it can’t last?
The tech bros believe we are close to conquering death. Matt Rudd travels to the ‘superhuman summit’ in Stockholm to sample body scanners and bone broth
www.thetimes.com
June 16, 2025 at 2:11 PM
Joe Betts-LaCroix (CEO of Retro Bio) has bigger concerns - he wants to add another ten years to the lifespan of half the world’s population.
“I’d like to know how my body works and, if it’s going to break, I’d like to know how to prevent that.”
www.thetimes.com/world/europe...
“I’d like to know how my body works and, if it’s going to break, I’d like to know how to prevent that.”
www.thetimes.com/world/europe...
“The Hidden Barriers Holding Back Cancer’s Most Promising Treatments” by Georgiamune CEO Samir N. Khleif for TIME.
time.com/7292783/canc...
time.com/7292783/canc...
The Hidden Barriers Holding Back Promising Cancer Treatments
A perfect storm of scientific, economic, and cultural barriers are holding back immunotherapy's true potential, writes Samir Khleif.
time.com
June 13, 2025 at 3:29 AM
“The Hidden Barriers Holding Back Cancer’s Most Promising Treatments” by Georgiamune CEO Samir N. Khleif for TIME.
time.com/7292783/canc...
time.com/7292783/canc...
Genesis Therapeutics Appoints Aleksandra Faust
as Chief Artificial Intelligence Officer.
Former Google DeepMind Director brings over two decades of AI research expertise and industrial leadership to Genesis’ AI platform and high-performing research teams.
www.businesswire.com/news/home/20...
as Chief Artificial Intelligence Officer.
Former Google DeepMind Director brings over two decades of AI research expertise and industrial leadership to Genesis’ AI platform and high-performing research teams.
www.businesswire.com/news/home/20...
Genesis Therapeutics Appoints Aleksandra Faust as Chief Artificial Intelligence Officer
Genesis Therapeutics appoints Aleksandra Faust as Chief Artificial Intelligence Officer
www.businesswire.com
June 13, 2025 at 3:26 AM
Genesis Therapeutics Appoints Aleksandra Faust
as Chief Artificial Intelligence Officer.
Former Google DeepMind Director brings over two decades of AI research expertise and industrial leadership to Genesis’ AI platform and high-performing research teams.
www.businesswire.com/news/home/20...
as Chief Artificial Intelligence Officer.
Former Google DeepMind Director brings over two decades of AI research expertise and industrial leadership to Genesis’ AI platform and high-performing research teams.
www.businesswire.com/news/home/20...
Reposted by Thermal
Thanks to the BBC's The Inquiry program for great conversations with IGI's @jenniferdoudna.bsky.social @doudna-lab.bsky.social and @urnov.bsky.social about Baby KJ, #CRISPR on-demand, and the future of personalized medicine!
Listen here: www.bbc.com/audio/play/w...
Photo credit: TODAY
Listen here: www.bbc.com/audio/play/w...
Photo credit: TODAY
June 12, 2025 at 9:20 PM
Thanks to the BBC's The Inquiry program for great conversations with IGI's @jenniferdoudna.bsky.social @doudna-lab.bsky.social and @urnov.bsky.social about Baby KJ, #CRISPR on-demand, and the future of personalized medicine!
Listen here: www.bbc.com/audio/play/w...
Photo credit: TODAY
Listen here: www.bbc.com/audio/play/w...
Photo credit: TODAY
🧬CRISPR is moving at breakneck speed! Join @jenniferdoudna.bsky.social and @emilychang.bsky.social on 6/5 for a live episode of #TheCircuit at #BloombergTech. From curing baby KJ to AIxCRISPR, this will be a candid conversation on gene editing's impact and future.
Livestream: www.bloomberg.com/live
Livestream: www.bloomberg.com/live
June 5, 2025 at 2:06 AM
🧬CRISPR is moving at breakneck speed! Join @jenniferdoudna.bsky.social and @emilychang.bsky.social on 6/5 for a live episode of #TheCircuit at #BloombergTech. From curing baby KJ to AIxCRISPR, this will be a candid conversation on gene editing's impact and future.
Livestream: www.bloomberg.com/live
Livestream: www.bloomberg.com/live
Reposted by Thermal
In case you needed a smile this Tuesday: 10-month-old baby KJ, who received a bespoke gene-editing therapy after a six month scientific sprint - "graduated" from the hospital @childrensphila.bsky.social today and went HOME!
YAY SCIENCE!
Here's his story: wapo.st/451ZQjT
YAY SCIENCE!
Here's his story: wapo.st/451ZQjT
June 3, 2025 at 8:39 PM
In case you needed a smile this Tuesday: 10-month-old baby KJ, who received a bespoke gene-editing therapy after a six month scientific sprint - "graduated" from the hospital @childrensphila.bsky.social today and went HOME!
YAY SCIENCE!
Here's his story: wapo.st/451ZQjT
YAY SCIENCE!
Here's his story: wapo.st/451ZQjT
BioAge Labs announced today a breakthrough dual-track approach to exercise mimetic obesity treatment that could solve major limitations of current GLP-1 therapies by targeting energy expenditure rather than just appetite suppression.
www.globenewswire.com/news-release...
www.globenewswire.com/news-release...
BioAge Expands APJ Agonist Pipeline with Oral Small-Molecule and Long-Acting Biologic Candidates
Company enters option agreement with JiKang Therapeutics to in-license novel APJ agonist antibody New composition of matter IP filed for chemically...
www.globenewswire.com
June 4, 2025 at 12:42 AM
BioAge Labs announced today a breakthrough dual-track approach to exercise mimetic obesity treatment that could solve major limitations of current GLP-1 therapies by targeting energy expenditure rather than just appetite suppression.
www.globenewswire.com/news-release...
www.globenewswire.com/news-release...
US supercomputer named after Nobel laureate Jennifer Doudna to power AI and scientific research
apnews.com/article/nvid...
apnews.com/article/nvid...
US supercomputer named after Nobel laureate Jennifer Doudna to power AI and scientific research
A new supercomputer named after a winner of the Nobel Prize in chemistry will help power artificial intelligence technology and scientific discoveries from a perch in the hills above the University of...
apnews.com
May 29, 2025 at 9:39 PM
US supercomputer named after Nobel laureate Jennifer Doudna to power AI and scientific research
apnews.com/article/nvid...
apnews.com/article/nvid...